• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

    6/4/25 7:31:28 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    unh-20250602
    0000731766false00007317662025-06-022025-06-02

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    —————————————
    FORM 8-K
    —————————————
    Current Report
    Pursuant to Section 13 or 15(d) of
    The Securities Exchange Act of 1934
    Date of report (Date of earliest event reported): June 2, 2025
    —————————————
    UNITEDHEALTH GROUP INCORPORATED
    (Exact name of registrant as specified in its charter)
    —————————————
    Delaware1-1086441-1321939
    (State or other jurisdiction of incorporation)
    (Commission File Number)
    (I.R.S. Employer Identification No.)
    1 Health Drive,655 New York Avenue NW
    Eden Prairie,Minnesota55344Washington,DC20001
    (Address of principal executive offices)(Zip Code)(Address of principal executive offices)(Zip Code)

    Registrant’s telephone number, including area code: (800) 328-5979
    N/A
    (Former name or former address, if changed since last report.)
    —————————————
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $.01 par valueUNHNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    ☐ Emerging growth company
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On June 2, 2025, the Compensation and Human Resources Committee of the Board of Directors of UnitedHealth Group Incorporated (the “Company”) cancelled the performance-based restricted stock units granted to Andrew Witty, the Company’s former Chief Executive Officer, on February 20, 2025. Mr. Witty agreed to the cancellation in connection with his retirement.

    Item 5.07.    Submission of Matters to a Vote of Security Holders.
    On June 2, 2025, the Company held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”). There were 811,952,044 shares of common stock represented at the Annual Meeting. The shareholders of the Company voted as follows on the following matters at the Annual Meeting:
    1.Election of Directors. The nine directors were elected at the Annual Meeting for a one-year term based upon the following votes:
    Director NomineeForAgainstAbstain
    Broker
    Non-Votes
    Charles Baker746,667,0164,423,1461,024,92659,836,956
    Timothy Flynn651,303,14199,158,7991,653,14859,836,956
    Paul Garcia746,536,9094,570,0921,008,08759,836,956
    Kristen Gil746,875,5784,264,517974,99359,836,956
    Stephen Hemsley697,580,14553,344,0001,190,94359,836,956
    Michele Hooper688,497,61562,277,7271,339,74659,836,956
    F. William McNabb III725,279,56025,647,7311,187,79759,836,956
    Valerie Montgomery Rice, M.D.714,336,65336,834,564943,87159,836,956
    John Noseworthy, M.D.644,851,636105,639,6311,623,82159,836,956
    2.Non-binding advisory vote on executive compensation. The Company’s executive compensation was approved by a non-binding advisory vote based upon the following votes:
    ForAgainstAbstain
    Broker
    Non-Votes
    451,227,441299,199,3221,688,32559,836,956

    3.Ratification of the appointment of Deloitte & Touche LLP. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025 was ratified based upon the following votes:
    ForAgainstAbstain
    762,684,17748,232,4751,035,392

    4.Shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. The shareholder proposal was not approved based upon the following votes:
    ForAgainstAbstain
    Broker
    Non-Votes
    94,676,898655,943,2081,494,98259,836,956






    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: June 4, 2025                 
    UNITEDHEALTH GROUP INCORPORATED
    By: /s/ Kuai H. Leong
    Kuai H. Leong
    Senior Deputy General Counsel and Deputy Corporate Secretary

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings